Necessity for surgical revision of defibrillator leads implanted long-term: Causes and management

Circulation

Volumn 117, Issue 21, 2008, Pages 2727-2733

  Eckstein, Jens ^a   Koller, Michael T ^b   Zabel, Markus ^c,d   Kalusche, Dietrich ^e   Schaer, Beat A ^a   Osswald, Stefan ^a   Sticherling, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Defibrillation; Defibrillators, implantable; Electrical stimulation; Heart arrest; Pacing

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEFIBRILLATOR; ELECTRIC POTENTIAL; EUROPE; FEMALE; FOLLOW UP; HEART PACING; HUMAN; IMPLANTATION; INCIDENCE; MALE; PRIORITY JOURNAL; RECIPIENT; RECURRENCE RISK; REOPERATION; TREATMENT FAILURE;

AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTRODES, IMPLANTED; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REOPERATION; RETROSPECTIVE STUDIES; TACHYCARDIA; TREATMENT OUTCOME;

EID: 44449116247     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.740670     Document Type: Article

References (20)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
2. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
4. Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M, Remp T, Durchlaub I, Gerth A, Steinbeck G, Hoffmann E. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol. 2003;14:38-43.
5. Gradaus R, Breithardt G, Bocker D. ICD leads: design and chronic dysfunctions. Pacing Clin Electrophysiol. 2003;26:649-657.
6. Luria D, Glikson M, Brady PA, Lexvold NY, Rasmussen MJ, Hodge DO, Chugh SS, Rea RF, Hayes DL, Hammill SC, Friedman PA. Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol. 2001;87:901-904.
7. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474-2480.
8. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, Dow M, Leffler J, Abeyratne A, Verness D. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003;41:73-80.
9. Pinski SL, Fahy GJ. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation. 1995;92:1651-1664.
10. Healy E, Goyal S, Browning C, Robotis D, Ramaswamy K, Rofino-Nadoworny K, Rosenthal L. Inappropriate ICD therapy due to proarrhythmic ICD shocks and hyperpolarization. Pacing Clin Electrophysiol. 2004;27:415-416.
11. Echt DS, Armstrong K, Schmidt P, Oyer PE, Stinson EB, Winkle RA. Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation. 1985;71:289-296.
12. Grunkemeier GL, Jin R, Eijkemans MJ, Takkenberg JJ. Actual and actuarial probabilities of competing risks: apples and lemons. Ann Thorac Surg. 2007;83:1586-1592.
13. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706.
14. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2006.
15. Grunkemeier GL, Anderson RP, Miller DC, Starr A. Time-related analysis of nonfatal heart valve complications: cumulative incidence (actual) versus Kaplan-Meier (actuarial). Circulation. 1997;96:70-74.
16. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol. 2005;28:926-932.
17. Mehta D, Nayak HM, Singson M, Chao S, Pe E, Camunas JL, Gomes JA. Late complications in patients with pectoral defibrillator implants with transvenous defibrillator lead systems: high incidence of insulation breakdown. Pacing Clin Electrophysiol. 1998;21:1893-1900.
18. Love CJ, Wilkoff BL, Byrd CL, Belott PH, Brinker JA, Fearnot NE, Friedman RA, Furman S, Goode LB, Hayes DL, Kawanishi DT, Parsonnet V, Reiser C, Van Zandt HJ. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training: North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol. 2000;23:544-551.
19. Wollmann CG, Bocker D, Loher A, Kobe J, Scheld HH, Breithardt GE, Gradaus R. Incidence of complications in patients with implantable cardioverter/ defibrillator who receive additional transvenous pace/sense leads. Pacing Clin Electrophysiol. 2005;28:795-800.
20. Mahapatra S, Homoud MK, Wang PJ, Estes NA 3rd, Link MS. Durability of repaired sensing leads equivalent to that of new leads in implantable cardioverter defibrillator patients with sensing abnormalities. Pacing Clin Electrophysiol. 2003;26:2225-2229.